The anti-inflammatory properties of GLP-1 are gaining attention, as chronic inflammation is a contributing factor in various metabolic disorders
(2001) Neural roles for heme oxygenase: contrasts to nitric oxide synthase
If your dose calculation exceeds that limit, you either need a larger syringe or should switch to the 17mg/mL concentration
There's a lot to unpack, so we've structured our thoughts into three distinct sectionsfeel free to peruse the whole post or jump forward to specific areas of interest using the links below: We'll start by sharing our about where the innovation race is headingand what it means for the industry key insights and predictions From there, we'll overview (including key differentiators between major competitors Eli Lilly and Novo Nordisk) what the race has looked to date Finally, we'll go deep on the that will define the innovation race moving forward: five vectors of innovation GLP-1 innovation: Key insights and predictions GLP-1s are more than a blockbuster drug class, they signal a profound reordering of how chronic disease is managed, financed, and even understood
MiR-132, an experience-dependent microRNA, is essential for visual cortex plasticity
These bacteria switch to producing porphyrins, the researchers explained, and in some people, this uptick in inflammatory compounds may contribute to acne